Saganda · Eli Lilly and Boehringer Ingelheim launch new heart health awareness campaign Eli Lilly...

3

Transcript of Saganda · Eli Lilly and Boehringer Ingelheim launch new heart health awareness campaign Eli Lilly...

Page 1: Saganda · Eli Lilly and Boehringer Ingelheim launch new heart health awareness campaign Eli Lilly and Boehringer Ingelheim launched a new disease awareness campaign in November partnering
Page 2: Saganda · Eli Lilly and Boehringer Ingelheim launch new heart health awareness campaign Eli Lilly and Boehringer Ingelheim launched a new disease awareness campaign in November partnering
Page 3: Saganda · Eli Lilly and Boehringer Ingelheim launch new heart health awareness campaign Eli Lilly and Boehringer Ingelheim launched a new disease awareness campaign in November partnering

Jingwei Gao Boehringer Ingelheim PharmaSUG China 2016 Paper PharmaSUG China 2016 … · 2016-11-29 · Jingwei Gao Boehringer Ingelheim PharmaSUG China 2016 Paper PharmaSUG China

Jingwei Gao Boehringer Ingelheim PharmaSUG China 2016 Paper PharmaSUG China 2016 … · 2016-11-29 · Jingwei Gao Boehringer Ingelheim PharmaSUG China 2016 Paper PharmaSUG China

Boehringer-Ingelheim: Creating your Online Success

Boehringer-Ingelheim: Creating your Online Success

HIGHLIGHTS OF PRESCRIBING INFORMATION - Boehringer Ingelheim

HIGHLIGHTS OF PRESCRIBING INFORMATION - Boehringer Ingelheim

Case 1:14-cv-13234-WGY Document 27 Filed 11/19/15 Page 1 of 12€¦ · 14-CV-13234-WGY BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM

Case 1:14-cv-13234-WGY Document 27 Filed 11/19/15 Page 1 of 12€¦ · 14-CV-13234-WGY BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM

Boehringer Ingelheim Introduction

Boehringer Ingelheim Introduction

RANITIDINE INJECTION USP - Boehringer Ingelheim

RANITIDINE INJECTION USP - Boehringer Ingelheim

Boehringer Ingelheim Expert Forum on Farm Animal well-being

Boehringer Ingelheim Expert Forum on Farm Animal well-being

TRANSFORMATION - Boehringer Ingelheim Annual Report 2019

TRANSFORMATION - Boehringer Ingelheim Annual Report 2019

Duloxetine Boehringer Ingelheim, INN - duloxetine · Duloxetine Boehringer Ingelheim . Duloxetine . Procedure No. EMEA/H/C/001007/P46/008 - Duloxetine Boehringer Ingelheim . CHMP

Duloxetine Boehringer Ingelheim, INN - duloxetine · Duloxetine Boehringer Ingelheim . Duloxetine . Procedure No. EMEA/H/C/001007/P46/008 - Duloxetine Boehringer Ingelheim . CHMP

Boehringer Ingelheim Research and Development Primed … · Boehringer Ingelheim Research and Development Primed ... (BRD). This will be used by the scientiflc community, ... our

Boehringer Ingelheim Research and Development Primed … · Boehringer Ingelheim Research and Development Primed ... (BRD). This will be used by the scientiflc community, ... our

2016/06 – IR – Business swap with Boehringer Ingelheim

2016/06 – IR – Business swap with Boehringer Ingelheim

Life in Boehringer Ingelheim

Life in Boehringer Ingelheim

Case M.7919 - SANOFI / BOEHRINGER INGELHEIM ......Subject: Case M.7919 – Sanofi / Boehringer Ingelheim Consumer Healthcare Business Commission decision pursuant to Article 6(1)(b)

Case M.7919 - SANOFI / BOEHRINGER INGELHEIM ......Subject: Case M.7919 – Sanofi / Boehringer Ingelheim Consumer Healthcare Business Commission decision pursuant to Article 6(1)(b)

Boehringer Ingelheim Pharmaceuticals Inc. PRADAXA ...

Boehringer Ingelheim Pharmaceuticals Inc. PRADAXA ...

CNS drug discovery at Boehringer Ingelheim...CNS drug discovery at Boehringer Ingelheim A fresh approach to neuropsychiatric diseases Dr. Paola Casarosa 24 April 2018 Boehringer Ingelheim

CNS drug discovery at Boehringer Ingelheim...CNS drug discovery at Boehringer Ingelheim A fresh approach to neuropsychiatric diseases Dr. Paola Casarosa 24 April 2018 Boehringer Ingelheim

LEVOCARNITINE INJECTION USP - Boehringer Ingelheim

LEVOCARNITINE INJECTION USP - Boehringer Ingelheim

Boehringer Ingelheim Strengthens its Commitment …...Boehringer Ingelheim has a long-term commitment to advance the treatment of cancer through the discovery of novel treatment options

Boehringer Ingelheim Strengthens its Commitment …...Boehringer Ingelheim has a long-term commitment to advance the treatment of cancer through the discovery of novel treatment options

“CHOOSING WISELY”? - Centro Bioetica · GF Gensini received fees and research support from Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, Johnson&Johnson, Pfizer,

“CHOOSING WISELY”? - Centro Bioetica · GF Gensini received fees and research support from Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, Johnson&Johnson, Pfizer,

Boehringer Ingelheim Corporate Social Responsibility Reportcsrreport.us.boehringer-ingelheim.com/pdfs/BI_GivingReport_English.pdf · Corporate Social Responsibility Report. Boehringer

Boehringer Ingelheim Corporate Social Responsibility Reportcsrreport.us.boehringer-ingelheim.com/pdfs/BI_GivingReport_English.pdf · Corporate Social Responsibility Report. Boehringer

BOEHRINGER INGELHEIM ANIMAL HEALTH …...BOEHRINGER INGELHEIM ANIMAL HEALTH #2 GLOBAL PLAYER BOEHRINGER INGELHEIM ANIMAL HEALTH BUSINESS UNIT FACT SHEET We have united the strengths

BOEHRINGER INGELHEIM ANIMAL HEALTH …...BOEHRINGER INGELHEIM ANIMAL HEALTH #2 GLOBAL PLAYER BOEHRINGER INGELHEIM ANIMAL HEALTH BUSINESS UNIT FACT SHEET We have united the strengths